Allstate Corp Neurocrine Biosciences Inc Call Options Transaction History
Allstate Corp
- $4.24 Billion
- Q3 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding NBIX
# of Institutions
687Shares Held
102MCall Options Held
290KPut Options Held
214K-
Black Rock Inc. New York, NY14.2MShares$2.01 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.81MShares$1.39 Billion0.02% of portfolio
-
Dodge & Cox San Francisco, CA5.57MShares$790 Million0.42% of portfolio
-
State Street Corp Boston, MA4.47MShares$634 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.09MShares$438 Million0.04% of portfolio
About NEUROCRINE BIOSCIENCES INC
- Ticker NBIX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 95,639,296
- Market Cap $13.6B
- Description
- Neurocrine Biosciences, Inc. discovers, develops, and markets pharmaceuticals for neurological, endocrine, and psychiatric disorders. The company's portfolio includes treatments for tardive dyskinesia, Parkinson's disease, endometriosis, and uterine fibroids, as well as clinical programs in various therapeutic areas. Its lead asset is INGREZZA, ...